A Novel Compound for Alcoholism Treatment: a Translational Strategy - Part II
Phase of Trial: Phase II
Latest Information Update: 28 Nov 2018
At a glance
- Drugs PF 5190457 (Primary)
- Indications Alcoholism
- Focus Therapeutic Use
- 19 Oct 2018 Planned primary completion date changed from 31 Dec 2018 to 31 Dec 2019.
- 06 Jul 2018 New trial record
- 28 Jun 2018 According to the University of Rhode Island media release, Akhlaghi is the co-principal investigator of this study.